{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:55:46Z","timestamp":1791924946288,"version":"4.3.4"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6668","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T18:12:17Z","timestamp":1477937537000},"page":"3175-3180","source":"Crossref","is-referenced-by-count":3,"title":["Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant"],"prefix":"10.2169","volume":"55","author":[{"given":"Taichi","family":"Ikebe","sequence":"first","affiliation":[{"name":"Department of Hematology, Almeida Memorial Hospital, Japan"},{"name":"Department of Hematology, Oita Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitohiro","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Almeida Memorial Hospital, Japan"},{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oita Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oita Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Ohtsuka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oita Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Saburi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oita Prefectural Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Shirao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 363: 1965-1976, 2004.","DOI":"10.1016\/S0140-6736(04)16412-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Robert-Gangneux F, Dard\u00e9 ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25: 264-296, 2012.","DOI":"10.1128\/CMR.05013-11"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sakikawa M, Noda S, Hanaoka M, et al. Anti-<i>Toxoplasma<\/i> antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol 19: 365-367, 2012.","DOI":"10.1128\/CVI.05486-11"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 327: 1643-1648, 1992.","DOI":"10.1056\/NEJM199212033272306"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cibickova L, Horacek J, Prasil P, et al. Cerebral toxoplasmosis in an allogeneic peripheral stem cell transplant recipient: case report and review of literature. Transpl Infect Dis 9: 332-335, 2007.","DOI":"10.1111\/j.1399-3062.2007.00224.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hakko E, Ozkan HA, Karaman K, Gulbas Z. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis 15: 575-580, 2013.","DOI":"10.1111\/tid.12138"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sumi M, Aosai F, Norose K, et al. Acute exacerbation of <i>Toxoplasma gondii<\/i> infection after hematopoietic stem cell transplantation: five case reports among 279 recipients. Int J Hematol 98: 214-222, 2013.","DOI":"10.1007\/s12185-013-1379-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Scerra S, Coignard-Biehler H, Lanternier F, et al. Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review. Eur J Clin Microbiol Infect Dis 32: 1259-1268, 2013.","DOI":"10.1007\/s10096-013-1879-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Green JA, Spruance SL, Cheson BD. Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin&apos;s disease. Cancer 45: 808-810, 1980.","DOI":"10.1002\/1097-0142(19800215)45:4<808::AID-CNCR2820450433>3.0.CO;2-C"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maciel E, Siqueira I, Queiroz AC, Melo A. <i>Toxoplasma gondii<\/i> myelitis in a patient with adult T-cell leukemia-lymphoma. Arq Neuropsiquiatr 58: 1107-1109, 2000.","DOI":"10.1590\/S0004-282X2000000600019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Martino R, Maertens J, Bretagne S, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 31: 1188-1195, 2000.","DOI":"10.1086\/317471"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Adurthi S, Sahoo T, Chakka K, et al. Acute toxoplasmosis in nonstem cell transplant patients with haematological malignancies: a study from a regional cancer institute in South India. Hematol Oncol 26: 229-233, 2008.","DOI":"10.1002\/hon.864"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Robak T. Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. Cancer Treat Rev 37: 3-10, 2011.","DOI":"10.1016\/j.ctrv.2010.05.003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ahmadzadeh A, Shahrabi S, Jaseb K, et al. BRAF mutation in hairy cell leukemia. Oncol Rev 8: 253, 2014.","DOI":"10.4081\/oncol.2014.253"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dasanu CA, Ichim TE, Alexandrescu DT. Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. Expert Opin Drug Saf 9: 55-64, 2010.","DOI":"10.1517\/14740330903427951"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matutes E, Wotherspoon A, Brito-Babapulle V, Catovsky D. The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 15: 184-186, 2001.","DOI":"10.1038\/sj.leu.2401999"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol 67: 291-297, 2010.","DOI":"10.1001\/archneurol.2010.3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Erdag N, Bhorade RM, Alberico RA, Yousuf N, Patel MR. Primary lymphoma of the central nervous system: typical and atypical CT and MR imaging appearances. AJR Am J Roentgenol 176: 1319-1326, 2001.","DOI":"10.2214\/ajr.176.5.1761319"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Utsuki S, Oka H, Abe K, et al. Primary central nervous system lymphoma in acquired immune deficiency syndrome mimicking toxoplasmosis. Brain Tumor Pathol 28: 83-87, 2011.","DOI":"10.1007\/s10014-010-0001-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chandana SR, Kotecha R, Al-Janadi A, Chang HT, Conley BA. Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma. J Clin Oncol 31: e186-e188, 2013.","DOI":"10.1200\/JCO.2012.44.8787"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Brogden RN, Sorkin EM. Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders. Drugs 46: 652-677, 1993.","DOI":"10.2165\/00003495-199346040-00006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shah GD, Yahalom J, Correa DD, et al. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25: 4730-4735, 2007.","DOI":"10.1200\/JCO.2007.12.5062"},{"key":"23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-199701000-00003","volume":"11","author":"P Cinque","year":"1997","unstructured":"23. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11: 1-17, 1997.","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.6668\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:28:47Z","timestamp":1498343327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/21\/55_55.6668\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":23,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6668","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}